<DOC>
	<DOC>NCT00871871</DOC>
	<brief_summary>This study will measure and compare changes in insulin production and sensitivity using the hyperglycemic clamp technique in obese patients with impaired glucose tolerance and hypertension treated with placebo, isosorbide mononitrate (ISMN) or hydrochlorothiazide (HCTZ).</brief_summary>
	<brief_title>Multiple Dose Effects of Hydrochlorothiazide and Isosorbide Mononitrate on Glucose Homeostasis (MK-0000-117)(Completed)</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Isosorbide</mesh_term>
	<mesh_term>Isosorbide-5-mononitrate</mesh_term>
	<mesh_term>Isosorbide Dinitrate</mesh_term>
	<criteria>Female participants must be postmenopausal Body Mass Index (BMI) of at least 29 kg/m^2 Weight has been stable over the past 3 months Has never been treated for hypertension or is diagnosed with hypertension taking up to 2 antihypertensive medications Willing to stop hypertension treatment for 14 days prior to randomization and throughout the study Does not have a history of diabetes In good health with the exception of hypertension No history of abnormal heart rhythms Part I only: willing to comply with high potassium/low sodium diet for the duration of the study Willing to avoid strenuous physical activity during the study Nonsmoker and/or has not used nicotine for at least 3 months and agrees to refrain from use of tobaccocontaining products throughout the study Agrees to refrain from consuming alcohol and caffeine during inpatient periods and to limit consumption at all other times during the study Agrees not to consume grapefruit, grapefruit products, and citrus, apple, and pineapple juices 2 weeks prior to administration of the first dose of study drug History of any illness that may make their participation in the study unsafe or confuse the study results Taking spironolactone or eplerenone Cannot refrain from using any prescription or nonprescription drugs during the study On a weight loss program and is not in the maintenance phase Started a weight loss drug within 8 weeks of the first study visit Consumes excessive amounts of alcohol or caffeine Has had major surgery, donated or lost 1 unit of blood within 4 weeks of the first study visit History of multiple and/or severe allergies to drugs or food Is dehydrated</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>